Novartis Q4 Profit, Sales Down, Core EPS Tops View; Lifts Dividend; Sees Growth In FY23
1/2 07:24
(RTTNews) - Swiss drug major Novartis AG (NVS) reported Wednesday that its fourth-quarter net income declined 91 percent to $1.47 billion from last year's $16.31 billion. Earnings per share were $0.69, down from $7.29 a year ago....